SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders purchased 1,200 call options on the company. This is an increase of approximately 1,438% compared to the average daily volume of 78 call options.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. SG Americas Securities LLC lifted its stake in shares of SIGA Technologies by 7.8% during the fourth quarter. SG Americas Securities LLC now owns 22,819 shares of the company’s stock worth $137,000 after purchasing an additional 1,652 shares in the last quarter. Rhumbline Advisers lifted its stake in shares of SIGA Technologies by 4.2% during the second quarter. Rhumbline Advisers now owns 69,947 shares of the company’s stock worth $531,000 after purchasing an additional 2,851 shares in the last quarter. Linden Thomas Advisory Services LLC lifted its stake in shares of SIGA Technologies by 21.6% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 24,292 shares of the company’s stock worth $146,000 after purchasing an additional 4,315 shares in the last quarter. Larson Financial Group LLC acquired a new position in shares of SIGA Technologies during the third quarter worth about $30,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in shares of SIGA Technologies by 30.0% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 19,902 shares of the company’s stock worth $120,000 after purchasing an additional 4,597 shares in the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.
SIGA Technologies Trading Up 1.1 %
SIGA stock opened at $6.39 on Thursday. The stock has a 50-day moving average price of $6.36 and a two-hundred day moving average price of $7.54. SIGA Technologies has a 12-month low of $4.26 and a 12-month high of $12.83. The company has a market cap of $456.28 million, a PE ratio of 5.33 and a beta of 0.94.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Recommended Stories
- Five stocks we like better than SIGA Technologies
- What is a Dividend King?
- Oracle Announces Game-Changing News for the AI Industry
- What is a Bond Market Holiday? How to Invest and Trade
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Why Are Stock Sectors Important to Successful Investing?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.